Latest

10:41
【Global X China Semiconductor ETF(03191.HK) up over 2%, giving leveraged exposure to China’s top chip names】Global X China Semiconductor ETF(03191.HK) is a Hong Kong-listed ETF that tracks the FTSE China Semiconductor & Semiconductor Equipment Index. Its 40-plus constituents cover China’s leading chip-design houses, foundries, equipment makers and OSAT players listed in Shanghai, Shenzhen or Hong Kong.
Tag： NewTimeSpace03191.HKGlobal X China Semiconductor ETF
10:37
【China Universal CSI All Share Investment Banking & Brokerage Index ETF (560090) Up 3.02%, Latest Size Reaches 3.528 Billion Yuan】As of 10:31 on January 6, 2026, Securities ETF Leader (560090) rose 3.02%, with the latest price at 1.36 yuan.
Tag： Securities ETF Leader560090.SHETF
10:25
【Samsung Blockchain Technologies Etf(03171.HK) — global blockchain exposure — up more than 4% for a second straight session.】Samsung Blockchain Technologies Etf(03171.HK) offers a professional vehicle for riding the sector’s growth. It combines a 30% link to spot-Bitcoin returns with a 70% basket of 20 global blockchain leaders
Tag： NewTimeSpace03171.HK
10:24
【Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517520) Rises 3.24%, Aiming for Third Consecutive Gain】As of 10:19 on January 6, 2026, Gold Stock ETF (517520) rose 3.24%, aiming for its third consecutive gain, with the latest price at 2.17 yuan.
Tag： Gold Stock ETF517520.SHETF
10:13
【China Merchants CSI Semiconductor Industry ETF (561980) Rises 4.78%, Scale Grows 221 Million Yuan in 2 Weeks】As of 10:07 on January 6, 2026, Semiconductor Equipment ETF (561980) rose 4.78%, with the latest price at 2.26 yuan.
Tag： Semiconductor Equipment ETF561980.SHETF
10:10
【AMUNDI FTSE China A50 Index ETF (82843.HK) up over 0.5%—the go-to single-day inverse hedge.】AMUNDI FTSE China A50 Index ETF (82843.HK) delivers the inverse daily return of the MSCI China A 50 Connect Index. Constituents are the 50 largest A-shares listed in mainland China and are regarded offshore as the bellwether for China’s “core assets.”
Tag： NewTimeSpace82843.OFAMUNDI FTSE China A50 Index ETF
09:58
【China Southern CSI SWS Non-Ferrous Metal ETF (512400) Up 2.3%+, Eyes Fourth Consecutive Gain】As of 09:42 on January 6, 2026, the Metal ETF (512400) rose 2.37%, aiming for its fourth consecutive gain, with the latest price at 2.03 yuan.
Tag： the Metal ETF512400.SHETF
08:59
【Early rally:E Fund (HK) MSCI China A50 Connect ETF (83111.HK)up more than 1.5%, a tool built for intraday hedges and lightning-quick trades】E Fund (HK) MSCI China A50 Connect ETF(83111.HK)​is an exchange-traded fund issued by E Fund Management Co., Ltd. that invests primarily in the MSCI China A50 Connect Index. The index comprises 50 A-share companies listed on mainland China’s major stock exchanges and is designed to deliver returns that closely track its performance.
Tag： NewTimeSpace83111.OF
08:22
【CATHAY PAC AIR(00293.HK): Announces Independent Committee Composition for Share Buyback】Cathay Pacific announced that Air China, after selling 108.08 million shares, has signed a deed to amend its irrevocable undertaking to cover 1,822,436,334 shares (approximately 27.11%), with all other material terms unchanged. Upon completion of the share buyback, Swire's holding will increase to 47.65% and Air China's to 29.98%. The Independent Board Committee will comprise four Independent Non-Executive Directors—Bernard Charnwut Chan, Christina Lee, Malcolm McRae, and Xiaobin Wang—with nominees from Swire or Air China excluded from membership.
Tag： CATHAY PAC AIR00293.HKAir China
08:13
【Air China(00753.HK)：Sells 108 Million Cathay Pacific Shares, Expects RMB182 Million Pre-Tax Gain】Air China (00753) announced that its wholly-owned subsidiary Easerich will place 108.08 million Cathay Pacific shares (approximately 1.61% of issued shares) with Morgan Stanley at HK$12.22 per share, expecting to realize a pre-tax profit of about RMB182 million. Post-transaction, Air China's stake will decrease to 27.11%, maintaining its position as an important strategic shareholder. The placement does not constitute a notifiable or connected transaction under Hong Kong Listing Rules and includes a 180-day lock-up period.
Tag： Air China00753.HKSale
07:24
【Bank of Zhengzhou(06196.HK): Regulatory Approval Obtained for Acquisition of Junxian and Yanling Rural Banks】Bank of Zhengzhou (6196.HK, 002936.SZ) has obtained regulatory approval to acquire Junxian Zhengyin Rural Bank and Yanling Zhengyin Rural Bank, establishing branches to take over all assets, liabilities, operations, and staff following asset verification. The approvals were issued by Hebi Financial Regulatory Sub-branch and the China National Financial Regulatory Administration Xuchang Regulatory Sub-branch in 2025.
Tag： Bank of Zhengzhou06196.HKacquisition
07:12
【JXR(01951.HK) :Narrows IVF Cycle Decline to 1.4% in 2025, Chengdu Flagship Hospital Posts 1.3% Growth】JXR(1951.HK) reported that its total IVF egg retrieval cycles reached 28,039 in 2025, narrowing the year-over-year decline to 1.4% and essentially recovering to 2024 levels. The Chengdu flagship hospital was a standout performer with 14,070 cycles, representing 1.3% growth, while the Greater Bay Area operation improved its decline from 13.5% in the first three quarters to 5.9% for the full year. Overseas markets (U.S. and Laos) also showed recovery, with the decline narrowing from 10.8% to 6.9%. The company has completed liquidation of its Laos operations.
Tag： JXR01951.HKBusiness Data
18:46
【Concord New Energy Group Limited to Secondary List on Singapore Exchange on January 6】Concord New Energy Group Limited announced that its ordinary shares are expected to be secondarily listed on the Main Board of the Singapore Exchange (SGX) and commence trading on January 6, 2026. The Company had previously obtained a listing eligibility letter from SGX, with the final listing subject to the fulfillment of relevant conditions and prevailing market conditions.
Tag： Concord New Energy Group Limited00182.HKSGX
17:10
【CanSino Biologics Announces Clinical Trial Approval for PCV24 Vaccine in China】CanSino Biologics Inc. announced that its self-developed 24-valent pneumococcal polysaccharide conjugate vaccine (PCV24) has received approval from the China National Medical Products Administration to proceed with clinical trials. The vaccine covers the major prevalent pneumococcal serotypes and is intended for individuals aged 2 months and above. Currently, no similar product is available on the market globally.
Tag： CanSino Biologics Inc.06185.HK
17:08
【LI-NING (02331.HK): Sets 2026 Cap for Restricted Share Award Plan, to Purchase 15 Million Shares for HK$300 Million】To meet the share vesting requirements under the Restricted Share Award Plan, the board of directors of LI-NING Company Limited has resolved to set an annual cap for the 2026 restricted share purchase period. The company intends to spend a maximum of HK$300 million to buy 15 million of its own shares in the open market. This transaction constitutes a continuing connected transaction as it involves connected persons.
Tag： LI-NING02331.HK
16:57
【Tianjin Tianbao Energy Co., Ltd. (01671.HK): Awarded AAA-level Top Credit Rating in Tianjin's Power Sales Industry, with Comprehensive Strength Recognized by Authorities】Tianjin Tianbao Energy Co., Ltd. announced that in December 2025, it was rated as the AAA-level top credit grade in the power sales industry by Tianjin Electric Power Trading Center, becoming one of the 13 power sales companies in Tianjin to receive this rating. Conducted through a comprehensive assessment across multiple dimensions including financial status and compliance management, this rating signifies that the company's core capabilities such as market-oriented transaction and risk control have gained high recognition from the industry.
Tag： Tianjin Tianbao Energy Co., Ltd.01671.HKCredit Rating
16:47
【Sunac China Completes Offshore Debt Restructuring, Winding-Up Petition Dismissed by Court】Sunac China Holdings Limited (01918.HK) announced that, following the completion of its comprehensive offshore debt restructuring on December 23, 2025, the Hong Kong High Court issued an order on January 5, 2026 to dismiss the winding-up petition. The petition was jointly applied for withdrawal by the company and the petitioner, China Cinda (HK) Asset Management Company Limited. Currently, the company has no outstanding winding-up petitions.
Tag： Sunac China01918.HKdebt restructuring
07:50
【SKB BIO-B(06990.HK): TROP2 ADC Combined with Immunotherapy Gets Breakthrough Designation, Accumulating Five Relevant Qualifications】On January 5, 2026, SKB BIO-B(06990.HK) issued an announcement stating that its core product sacituzumab govitecan (SAC-TMT) in combination with pembrolizumab for the first-line treatment of specific PD-L1-positive locally advanced or metastatic non-small cell lung cancer has been granted Breakthrough Therapy Designation by the NMPA. This designation supports subsequent conditional approval and priority review applications to accelerate the launch of the indication. Previous relevant Phase 3 clinical trials have shown significant clinical benefits, and the product has accumulated five Breakthrough Therapy Designations, with three indications approved in China and two included in medical insurance. The company and MSD are also advancing multiple clinical studies globally, while the announcement reminds that the development and commercialization of unapproved indications are subject to uncertainties.
Tag： SKB BIO-B06990.HKinnovative drug
22:00
【Zhongzheng International Company Limited (00943.HK): Acquires beauty industry digital service provider for HK$62.5 million, resumption of trading on January 5】Zhongzheng International entered into an acquisition agreement with the seller, proposing to acquire all equity interests in the target company (a digital service provider in the beauty industry) and the outstanding shareholder loans for HK$62.5 million. The consideration will be settled by issuing 342 million consideration shares at HK$0.1828 per share.
Tag： Zhongzheng International00943.HKacquire
21:55
【Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.(01349.HK): Invests RMB210 million in SPD Bank structured deposits to enhance idle fund returns】Fudan Zhangjiang entered into an agreement with SPD Bank to subscribe to a structured deposit product with RMB210 million of its own idle funds generated from daily operations. The product is a principal-guaranteed floating-income type with a term of 87 days, an expected annualized return rate ranging from 0.70% to 1.90%, and is linked to the euro-to-U.S. dollar exchange rate.
Tag： Fudan Zhangjiang01349.HKsubscribe
Previous1..570571572 573574     574 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments